NCT02889510 - Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 4, 2016

Primary Completion Date

November 18, 2019

Study Completion Date

December 16, 2019

Conditions

Type 2 Diabetes

Interventions

DRUG

liraglutide

7-week subcutaneous liraglutide once daily

DRUG

placebo

7-week subcutaneous placebo once daily

Trial Locations (6)

Hospital Universitari Arnau de Vilanova de Lleida, Lleida

Hospital Universitario Virgen de la Victoria, Málaga

Clínica Universidad de Navarra, Pamplona

Hospital Universitario Virgen del Rocío, Seville

Hospital Universitari Germans Trias i Pujol, Badalona

Hospital Universitari Vall d´Hebrón, Barcelona